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Mastitis was identified as a priority disease within the Irish dairy industry by both 
dairy farmers and industry animal health experts, which led to the development of 
the CellCheck programme. In order to support this programme it was necessary to 
understand the extent to which mastitis affects farm profit, processor returns and 
ultimately industry profitability. To this end, an analysis of the impact of mastitis on 
farm, processor and the overall industry profitability was carried out. The impact of 
mastitis on farm costs, farm receipts and farm profitability is presented across a range 
of bulk milk somatic cell count (SCC) categories from <100,000 to >400,000 cells/mL. 
A meta-analysis of the relationship between SCC and raw milk composition, cheese 
processing characteristics and cheese composition was carried out and utilised to 
establish the impact of mastitis on processor returns. As SCC increased, the impact of 
mastitis on the volume of product that could be produced, net processor returns, milk 
price and the values per kg of fat and protein were calculated. The farm and proces-
sor analysis were then combined to estimate the impact of mastitis on the Irish dairy 
industry returns, accounting for both farm and processor costs. The analysis suggests 
that as cell count reduced from >400,000 to <100,000 cells/mL, overall returns to 
the farm should increase by 4.8 c/L, including the farm and processor related effects. 
Nationally, if the cell count was reduced by 10%, it would be worth €37.6 million for the 
Irish dairy industry. 
Keywords: costs; dairy industry; economics; mastitis; somatic cell count 
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Introduction
Berry et al. (2006) documented the tem-
poral trends in bulk milk tank somatic 
cell counts (BMSCC) in Irish dairy herds 
from 1994 to 2004. That analysis showed 
that between 2000 and 2004 there was an 
annual increase in SCC of 2,000 cells/mL in 
BMSCC, resulting in a national geometric 
mean of 250,937 cells/mL in 2004. Recent 
estimates based on 2011 data suggest that 
the national average BMSCC has increased 
(Teagasc 2012). This upward trend in the 
national BMSCC has negative implications 
at farm, processor and industry level in 
terms of suppressed milk production, high-
er culling rates, higher on-farm costs, lower 
product yields and lower product quality, all 
of which ultimately have a negative impact 
on farm, processor and industry profit. 
In 2009, dairy farmers and industry 
animal health experts identified udder 
health and milk quality as a priority animal 
health issue on Irish dairy farms (More 
et al. 2010). This led to the development 
of the CellCheck programme. However, 
in order for this programme to address 
the issues, it was necessary to quantify the 
current cost of mastitis to the Irish dairy 
industry. This would indicate the motiva-
tion required for farmers and processors 
to acknowledge the scale of the problem 
and thus implement effective manage-
ment practices. To address this data gap, 
research was conducted on the impact of 
mastitis on farm profitability, processor 
profitability, value of milk and overall 
profitability of the Irish dairy industry. 
The purpose of this article is to provide a 
single source which succinctly summarises 
this research, which has numerous appli-
cations for the Irish dairy industry.
Farm Profitability and Mastitis
The analysis carried out by Geary et al. 
(2012a) to examine the impact of mastitis 
on farm profitability followed similar meth-
odologies to the international research in 
the area (Bar et al. 2008; Huijps, Lam 
and Hogeveen 2008; Hagnestam-Nielsen 
and Ostergaard 2009). To carry out this 
analysis, data on the farm specific costs of 
mastitis on Irish dairy farms were collat-
ed and incorporated into the Moorepark 
Dairy Systems Model (MDSM) (Shalloo 
et al. 2004). The MDSM then calculated 
total farm costs, total farm receipts, net 
farm profit and the margin per litre for 
a 40 hectare farm. Five distinct BMSCC 
categories were examined in the analy-
sis; 100,000, 100,001–200,000, 200,001–
300,000, 300,001–400,000 and >400,000 
cells/mL. 
Moorepark dairy systems model 
The MDSM (Shalloo et al. 2004) is a 
stochastic budgetary simulation model of 
a typical Irish dairy farm. It allows inves-
tigation of the effects of varying biologi-
cal, technical, and physical processes on 
farm profitability. The model integrates 
animal inventory, milk production, feed 
requirements, land and labour utilisation, 
to provide an economic analysis of the 
production system. The outputs of the 
MDSM include financial indicators (cash 
flow, profit and loss and balance sheet) 
and physical outputs (feed budget, nutri-
ent balance sheet and physical ratios). For 
each BMSCC category, total farm receipts 
(milk and livestock receipts), total farm 
costs (variable and fixed costs and depre-
ciation), and net farm profit (total farm 
receipts – total farm costs) were calculat-
ed. A thorough description of the MDSM 
model and the incorporated mastitis com-
ponents is available in Shalloo et al. (2004) 
and Geary et al. (2012b).
Farm specific costs of mastitis 
Data on the Irish farm specific costs of 
mastitis were taken from a number of 
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sources including Kelly (2009), the Irish 
Cattle Breeding Federation (ICBF 2010) 
milk recording database, survey data col-
lected from the Herd Ahead Programme 
(Sayers 2009) and a Mastitis Farm Practice 
survey administered to a sample of the 
Herd Ahead farmers (full detailed descrip-
tion available in Geary et al. 2012a). 
Reduced milk production
Kelly (2009) examined the relationship 
between SCC and milk yield across par-
ities, accounting for stage of lactation 
and calving month. Using the ICBF milk 
recording data, Kelly (2009) estimated 
the average milk losses per day across the 
lactation for parity 1 to 5 cows across each 
of the 5 BMSCC categories. This data was 
coupled with the average parity structure 
of Irish dairy farms for each BMSCC 
category which was based on ICBF data. 
The estimated volume of reduced milk 
production per cow over the length of 
the lactation for each BMSCC category is 
presented in Table 1. The price per litre of 
unrealised milk was assumed at 27 cents 
per litre (Binfield et al. 2008).
Diagnostic testing
Information on the mastitis diagnostic 
testing practices on Irish dairy farms were 
collected from the Mastitis Farm Practice 
Survey and coupled with the ICBF data to 
capture the testing practices by BMSCC 
category. Table 1 summarises the pro-
portion of farms carrying out bulk tank 
and individual cow milk culture analysis. 
A cost per milk culture of €5.05 was 
assumed in the analysis (Department of 
Agriculture, Food and the Marine 2011).
Cases treated
The number of subclinical cases treated 
was identified from the Mastitis Farm 
Practice Survey and coupled with herd size 
and BMSCC data from the ICBF database 
to calculate the proportion of the herd 
treated for subclinical mastitis across the 
five BMSCC categories. The number of 
clinical mastitis cases treated was calcu-
lated in a similar way but was obtained 
from the Herd Ahead Programme (Sayers 
2009). Generally, as BMSCC increased 
the proportion of the herd treated for 
clinical mastitis increased. Table 1 sum-
marises the clinical and subclinical masti-
tis treatment practices and rates for each 
BMSCC category. 
Treatment and veterinary attention
Data on mastitis treatment procedures 
on Irish dairy farms were obtained from 
the Mastitis Farm Practice Survey; the 
proportion of cases of mastitis (clinical 
or subclinical) treated with (i) intramam-
mary tubes only, (ii) injectable antibiotics 
only, (iii) a combination of both and (iv) 
pain relief were included in the analysis. 
The costs of injectable antibiotics were 
weighted by severity: mild cases incurred 
the cost of intramuscular antibiotics while 
severe cases incurred the cost of intra-
venous antibiotics and veterinary atten-
tion. The assumed cost per treatment 
with intramammary tubes was €9.90, with 
injectable antibiotic (weighted by severity) 
was €21.26 and pain relief administered 
was €16.50.  
Discarded milk
Milk from mastitic cows treated with anti-
biotics was assumed to be withheld from 
the tank for 5 days (3 days treatment, 2 
days post treatment) to avoid antibiotic 
residues in the milk supplied to proces-
sors. High SCC milk or antibiotic residue 
milk is fed to calves on the majority of 
farms (Mastitis Farm Practice Survey), 
however, this is only feasible while the 
calves are available to consume the milk. 
Therefore, it was assumed in the MDSM 
that all discarded milk was fed to calves 
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between January and May until calves 
were weaned; thereafter, the milk was dis-
carded. The proportion of farms discard-
ing milk across each BMSCC threshold is 
summarised in Table 1 and is based on the 
clinical and subclinical cases treated. 
Culling
The proportion of the herd culled due to 
mastitis was estimated from the Mastitis 
Farm Practice Survey in conjunction with 
ICBF data. As SCC increased, the pro-
portion of the herd culled due to mastitis 
increased from 3% at a BMSCC <100,000 
cells/mL to 13% at a BMSCC of >400,000 
cells/mL (Table 1). The value of a culled 
cow was assumed at €400, while the cost 
of a replacement heifer was assumed at 
€1,451 (Geary et al. 2012a).
The seasonality of SCC was accounted 
for in the analysis by applying a weighting 
to the monthly SCC in the MDSM. This 
was done by utilising data from Berry et al. 
(2006) which documented the monthly 
trend in geometric mean SCC using Irish 
data. The biological and cost data, for 
each of the BMSCC categories, were 
incorporated into the MDSM model to 
estimate the effect that mastitis costs have 
on the profitability of a 40 hectare farm 
(holding land area constant). 
Farm Results
Physical results
As BMSCC increased the volume of milk 
delivered decreased, the replacement 
rate increased and milk solids per cow 
decreased for an average 40 hectare farm 
(Table 2). The decrease in milk delivered 
reflected the reduced milk production as 
BMSCC increased as well as replacing 
multiparous cows with primiparous cows. 
The replacement rate increased from 19% 
at <100,000 cells/mL at a cost of €25,550 
to 28% at >400,000 cells/mL at a cost of 
€40,709. 
Financial results
Total farm receipts decreased as BMSCC 
increased, which incorporated the 
reduced milk returns and increased live-
stock receipts from cull cows as BMSCC 
Table 2. Impact of mastitis on the physical and financial outputs of a typical 40 hectare Irish dairy farm 
across 5 bulk milk somatic cell count categories
Model outputs
Somatic cell count categories (‘000)
<100
(Baseline)
100–200 200–300 300–400 >4001
Physical outputs Cows calving 94 96 99 100 101
Milk delivered (kg) 532,122 524,614 518,834 516,198 513,596
Replacement rate (%) 19 20 24 26 28
Kg MS2( kg) 37,530 36,995 36,573 36,380 36,190
MS2 per cow (kg) 411 397 382 376 370
Financial outputs Total farm receipts (€) 192,147 191,617 192,342 190,431 189,091
Total farm receipts (cents/kg) 36.1 36.5 37.1 36.9 36.8
Total farm costs (€) 161,085 164,994 172,749 173,536 177,343
Total farm costs (cents/kg) 30.3 31.5 33.3 33.6 34.5
Net farm profit (€) 31,252 26,771 19,661 16,936 11,748
Net farm profit/kg (cents/kg) 5.9 5.1 3.8 3.3 2.3
1The outputs for the >400,000 cells/mL BMSCC category were based on extrapolated assumptions using 
the data from the 200,000-300,000 cells/mL and the 300,000-400,000 cells/mL categories.
2Milk solids.
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increased (Table 2). Total farm costs 
increased as BMSCC increased, which 
reflected the increased costs of treat-
ing mastitis cases on the farm and the 
increased cost of purchasing/rearing 
replacement heifers. Overall the net farm 
profit decreased by €19,504 (from €31,252 
to €11,748) for a 40 hectare farm, as 
BMSCC increased from <100,000 cells/mL 
to >400,000 cells/mL. 
Processor Profitability and Mastitis
Estimating the impact of mastitis at pro-
cessor level, in terms of production and 
revenue, relative to the farm analysis has 
not been examined to the same extent in 
the international literature. To carry out this 
analysis the relationship between BMSCC 
and (i) raw milk composition, (ii) cheese 
processing characteristics and (iii) cheese 
composition needed to be elucidated. Due 
to the variability in the literature on the 
relationship between BMSCC and raw milk 
and cheese, a meta-analysis was carried out.
Meta-analysis
Meta-analysis allows the results of many 
studies to be combined, consequently 
the pooled dataset has greater power 
than individual studies to detect small 
but significant effects and gives more pre-
cise estimates of the size of the effects 
(Crombie and Davies 2009; St-Pierre 
2001). To carry out the meta-analysis the 
literature was reviewed and two databases 
were developed; the first pooled data from 
32 scientific articles on the relationship 
between SCC and raw milk composition, 
the second pooled data from 13 scien-
tific articles on the relationship between 
SCC and cheese processing and cheese 
composition. As SCC increased, changes 
in (1) milk composition and (2) cheese 
processing and composition were analysed 
with random regression models using the 
MIXED procedure in SAS 9.3 (SAS 2010).
The analysis showed that as SCC 
increased the crude protein, true protein, 
non protein nitrogen, total nitrogen, whey 
protein and fat content of milk significant-
ly increased (Table 3). As SCC increased, 
the lactose and casein as a percentage of 
true protein content of milk significantly 
decreased. Fat and protein recovery dur-
ing processing was significantly decreased 
(Table 3). The moisture content of cheese 
was found to increase significantly as SCC 
increased while the protein content of 
cheese decreased significantly (Table 3). 
The results of the meta-analysis high-
lighted that increased SCC was associated 
Table 3. Significant relationships between somatic cell score and raw milk composition, cheese processing 
and cheese composition1
 Intercept SE  P-value  Slope  SE  P-value
Raw milk composition
 Crude protein (%)  1.8923  0.4760 0.0004  0.0842  0.0277 0.0049
 Casein as a percentage of true protein (%) 95.7043  6.1059 <0.0001 -0.9668 0.3288 0.0078
 Fat (%)  1.7409  0.8357 0.0476  0.1175  0.0471 0.0196
 Lactose (%)  7.2808  0.7234 <0.0001 -0.1468 0.0409 0.0019
Cheese processing
 Protein recovery (%)  86.0994  4.5510 0.0003  -0.5737 0.2398 0.0965
 Fat recovery (%)  103.9300  4.5683 0.0002  -0.7083 0.2742 0.0815
Cheese composition
 Moisture (%)  30.0559  4.2257 <0.0001 0.5457  0.1973 0.0199
 Protein in cheese (%)  29.5445  2.2800 <0.0001 -0.2680 0.1272 0.0890
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with raw milk composition changes along 
with changes in cheese production char-
acteristics and cheese composition. 
However, the effect of these changes on 
product yield and net milk receipts was 
still unclear. To answer this question the 
outputs of the meta-analysis were incor-
porated into the Moorepark Processing 
Sector Model (MPSM) (Geary et al. 2010). 
Impact of mastitis on processor profitability – 
Moorepark Processing Sector Model
The MPSM is described in detail by Geary 
et al. (2010; 2012b; 2013). Briefly the 
approach uses a mass balance milk pro-
cessing-sector model that accounts for all 
inputs, outputs and losses involved in dairy 
processing. The model is a mathematical 
representation of the conversion of milk 
into dairy products [cheese, casein, but-
ter, whole milk powder (WMP), skim milk 
powder (SMP), fluid milk, by-products of 
butter milk powder (BMP), whey powder 
(WP) and cream]. The proportion of milk 
that is directed toward the production of 
each product is specified in the model. The 
quantities of products and by-products that 
can be produced from the available milk 
pool, with given product specifications, are 
calculated, processing costs are estimated, 
the returns from the products produced 
are generated, the net revenue is deter-
mined (total revenue – total costs), the 
values per kg of fat and per kg of protein 
are derived and the milk price is calcu-
lated. Similar to the farm analysis, the five 
BMSCC categories of 100,000, 100,001–
200,000, 200,001–300,000, 300,001–400,000 
and >400,000 cells/mL were examined in 
the MPSM. For each BMSCC category 
the raw milk composition, cheese pro-
duction and cheese composition variables 
were modified based on the findings of 
the meta-analysis. In addition, changes in 
SMP and WMP compositions were also 
assumed based on the available literature. 
Model inputs
The key model inputs in the MPSM are 
the volume of milk supplied, the milk 
supply profile, the product mix being pro-
duced, processing costs and the product 
market values. In addition, specific for this 
analysis, the relationship between SCC 
and (i) the raw milk composition, (ii) 
cheese production and (iii) cheese compo-
sition variables were incorporated into the 
model as inputs. 
Raw milk The volume of milk supplied in 
this analysis was 5,377 million litres, repre-
sentative of the volume of milk processed 
in Ireland in 2011 (Central Statistics Office 
[CSO] 2011). The national mean SCC in 
Ireland was estimated at 281,000 cells/
mL (Aine O’Connell personal communi-
cation), therefore, the 200,001–300,000 
cells/mL BMSCC category was represen-
tative of the current national dairy indus-
try and was assumed as the baseline. The 
baseline raw milk composition was also 
sourced from CSO data (CSO 2011). The 
findings of the meta-analysis were applied 
to the baseline milk composition to esti-
mate the composition of milk for the other 
four BMSCC categories. The composi-
tion of raw milk assumed for each of the 
BMSCC categories is presented in Table 4.
Cheese production The current industry 
fat and protein recoveries from industry 
consultation were assumed to be repre-
sentative of the baseline BMSCC category 
(200,001–300,000 cells/mL). The findings 
of the meta-analysis were applied to these 
to estimate the recoveries for each of the 
remaining BMSCC categories. Fat recov-
ery decreased with increasing SCC; at a 
BMSCC of <100,000 cells/mL fat recovery 
was 94.12% which decreased to 92.70% 
at a BMSCC of >400,000 cells/mL. 
Protein recovery also decreased as SCC 
increased from 99.91% at a BMSCC of 
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<100,000 cells/mL to 98.76% at a BMSCC 
of >400,000 cells/mL.
Product composition Table 5 summarises 
the cheese, SMP, WMP and butter com-
positions assumed for each of the BMSCC 
categories.
Utilising the baseline (200,001–300,000 
cells/mL) cheese moisture (35.26%) and 
cheese protein (24.50%), the findings of the 
meta-analysis were applied to  calculate the 
SCC adjusted moisture and protein content 
of cheese. Very little literature is avail-
able on the relationship between SCC and 
the composition of SMP and WMP. The 
baseline composition of SMP and WMP 
(200,001–300,000 cells/mL) assumed in 
this analysis was reflective of the average 
composition of these products in Ireland 
(industry consultation). The composition 
of SMP and WMP for each of the other 
BMSCC categories was calculated using the 
incremental changes from the baseline as 
reported by Rogers and Mitchell (1989) and 
Auldist et al. (1996), respectively. There was 
no literature to support a change in butter 
composition as SCC increased, therefore 
the baseline was assumed throughout. 
Each of these inputs was incorporated 
into the MPSM for each BMSCC category. 
The MPSM estimated the net revenue, the 
value per kg of fat and per kg of protein 
and the price per litre of milk within each 
BMSCC category.
Processor Results
Production volumes As BMSCC increased 
from <100,000 cells/mL to >400,000 
cells/mL the quantity of cheese, but-
ter, WMP, SMP and WP that could be 
produced from the available milk pool 
decreased by 4,217 (21.%), 623 (0.5%), 
9,881 (9.6%), 7,568 (3.0%) and 2,052 
(2.1%) tonnes, respectively. The potential 
volumes of cheese that could be manufac-
tured highlighted that the reductions in 
the fat and protein recoveries were more 
significant than the increases in the milk 
solids content.
Revenue As BMSCC increased from 
<100,000 cells/mL to >400,000 cells/mL 
the net revenue generated decreased by 
3.2% or €51.3 million per annum (Table 6). 
This reduction was driven by the reduction 
in the quantity of product available for sale.
Milk price As  BMSCC increased from 
<100,000 cells/mL to >400,000 cells/mL 
Table 4. Average fat, protein and lactose content of milk for each bulk milk somatic cell count category.
Bulk milk somatic cell count category (‘000)
<1003 100–2003 200–300
Baseline1
300–4003 >4003
Annual average fat content of milk (%) 3.70 3.82 3.89 3.94 3.98
Annual average protein content of milk (%) 3.24 3.32 3.37 3.41 3.43
Annual average lactose content of milk2 (%) 4.85 4.70 4.61 4.55 4.50
Annual average casein in protein content of milk (%) 81.53 80.57 80.00 79.60 79.29
1Baseline milk volume, fat and protein content of milk were sourced from CSO Milk statistics 2011 and are 
representative of the national milk pool and national somatic cell count. 
2Baseline lactose content of milk was predicted using the Moorepark Dairy Systems Model (Shalloo et al. 
2004), the lactose content of milk for the other SCC categories was calculated using the results of a meta-
analysis.
3Fat, protein and casein in protein content of milk for the other four bulk milk somatic cell count categories 
was calculated using the results of a meta-analysis. 
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the average milk price decreased by 0.96 
cents per litre. 
Component values of milk The value per 
kg of fat decreased by €0.04 cents/kg and 
the value per kg of protein decreased by 
€0.24 cents/kg as BMSCC increased from 
<100,000 cells/mL to >400,000 cells/mL 
(Table 6). 
Industry Profitability and Mastitis
The farm and processor analysis were 
combined to examine the impact of 
mastitis on overall industry profitability. 
The values per kg of fat and protein calcu-
lated in the MPSM were incorporated into 
the MDSM to estimate the net farm profit 
and the margin per litre for each BMSCC 
category. This calculated net farm profit 
and margin per litre accounted for (i) the 
farm specific costs of mastitis and (ii) the 
processor effects of mastitis (the returns at 
processor level as BMSCC changed were 
incorporated into the farm analysis via 
the euro value per kg of fat and protein). 
This analysis generated a net farm profit 
of €43,328 for a 40 hectare farm with a 
Table 5. Composition of dairy products produced for each bulk milk somatic cell count category assumed in 
the Moorepark Processing Sector Model
Product Bulk Milk Somatic Cell Count category (‘000)
Cheese1 <100 100–200
200–300
Baseline 300–400 >400
Fat (%) 35.00 35.00 35.00 35.00 35.00
Protein (%) 25.92 24.66 24.50 24.39 24.39
Lactose (%) 1.39 1.39 1.39 1.39 1.39
Moisture (%) 34.40 34.94 35.26 35.48 35.49
SMP2, 5 <100 100–200 200–300 300–400 >400
Fat (%) 1.00 1.00 1.16 1.16 1.23
Protein (%) 33.00 33.00 35.37 35.37 35.93
Lactose (%) 54.00 54.00 52.17 52.17 51.28
Moisture (%) 4.00 4.00 3.05 3.05 3.18
WMP3, 5 <100 100–200 200–300 300–400 >400
Fat (%) 27.00 27.00 27.60 27.60 27.30
Protein (%) 25.00 25.00 28.30 28.30 27.50
Lactose (%) 40.00 40.00 25.70 35.70 37.30
Moisture (%) 3.00 3.00 2.80 2.80 2.70
Butter4 <100 100–200 200–300 300–400 >400
Fat (%) 84.00 84.00 84.00 84.00 84.00
Protein (%) 0.59 0.59 0.59 0.59 0.59
Lactose (%) 0.79 0.79 0.79 0.79 0.79
Moisture (%) 14.50 14.50 14.50 14.50 14.50
1Protein and moisture percentage of cheese calculated using results of meta analysis. 
2SMP composition <100,000 and 100,001–200,000 cells/mL assumed generic values, unaffected by SCC. 
Incremental changes in SMP composition calculated based on Rogers and Mitchell (1989).
3WMP composition <100,000 and 100,001–200,000 cells/mL assumed generic values, unaffected by SCC. 
Incremental changes in WMP composition calculated based on Auldist et al. (1996).
4No evidence to suggest a change in the composition of butter, BMP, or WP as SCC increased.
5SMP: skim milk powder; WMP: whole milk powder. 
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BMSCC <100,000 cells/mL, decreasing 
to €18,490 with a BMSCC of >400,000 
cells/mL, a difference of €24,838 (Table 7). 
This equated to a margin of 8.4 cents/L at 
a BMSCC of <100,000 cells/mL and 3.6 
cents/L at a BMSCC of >400,000 cells/mL 
(Table 7). 
To estimate industry returns (farm and 
processor) the margin per litre for each 
BMSCC category was multiplied by the 
volume of milk supplied nationally by 
dairy farmers to milk processors within 
each BMSCC category.
Industry returns
National BMSCC profile To estimate the 
SCC profile of the national milk pool, 
analysis was carried out by O’Connell 
(personal communication) examining bulk 
tank milk quality data from ten Irish milk 
processors representing 11,444 suppliers 
from across the Republic of Ireland. In 
total 687,821 records of SCC were avail-
able for inclusion in the analysis across 
63,166 herd-years. The data was analysed 
using SAS 9.3 (SAS, 2010). The dataset 
was stratified into each of the five BMSCC 
categories from <100,000 to >400,000 
cells/mL and the percentage of monthly 
observations in each BMSCC category was 
calculated. The proportion of the national 
milk pool supplied within each BMSCC 
category was calculated by multiplying the 
monthly milk supply profile by the month-
ly SCC profile of milk supplied. The calcu-
lated proportion of the national milk pool 
Table 6. Annual net revenue, milk price and component values of milk for each bulk milk somatic cell count 
category when 5,377 million litres/year were processed into a representative mix of dairy products in the 
Irish dairy industry
Financial outputs
Bulk milk somatic cell count category (‘000)
<100 100–200 200–300
Baseline
300–400 >400
Net revenue (€m)1, 1,617.2 1,591.2 1,571.4 1,559.8 1,565.9
Milk value (cents/L)2 30.08 29.59 29.22 29.01 29.12
Component values of milk in the milk pricing system 
Fat value/kg (€)3 3.03 2.99 2.95 2.94 2.99
Protein value/kg (€)4 5.99 5.89 5.83 5.78 5.75
1Net revenue (total revenue – total costs).
2Average milk price paid throughout the year (net revenue/total volume of milk processed).
3Average value per kg of fat paid throughout the year within the milk pricing system.
4Average value per kg of protein paid throughout the year within the milk pricing system.
Table 7. Impact of mastitis on the financial outputs of Irish dairy farms across 5 somatic cell count (SCC) 
categories incorporating the returns at processor level, holding land area constant at 40 hectares
Somatic Cell Count Categories (‘000 cells/mL)
<100 100–200 200–300 300–400 >400
Total farm receipts (€) 204,160 201,081 199,602 196,540 195,804
Total farm receipts/kg (cents/kg) 38.37 38.33 38.47 38.07 38.12
Total farm costs € 161,085 164,994 172,749 173,536 177,343
Total farm costs/kg (cents/kg) 30.27 31.45 33.30 33.62 34.53
Net farm profit (€) 43,328 36,280 26,954 23,071 18,490
Margin per litre (cents/L) 8.4 7.1 5.4 4.5 3.6
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supplied within each BMSCC category is 
presented in Table 8. These proportions 
were applied to the volume of milk pro-
cessed nationally in 2012 (5,224.7 million 
litres; CSO 2012) to estimate the volume 
of milk supplied within each BMSCC 
category. 
Industry returns The current industry 
returns were calculated by multiplying the 
margin per litre for each BMSCC category 
by the volume of milk supplied within each 
BMSCC category nationally and summing 
the five calculations. This value represent-
ed the baseline industry returns. 
A movement of producers from one cell 
count category to the next lower cell count 
category where possible (i.e. at lowest cell 
count category there is no movement), was 
examined. Three scenarios were explored, 
i.e., a 10% movement, 20% movement 
and 30% movement of producers from 
higher to lower SCC categories. Table 8 
summarises (i) the proportion of milk sup-
plied within each BMSCC category and 
(ii) the national average SCC for the base-
line and scenarios analysed. The improved 
industry returns were again calculated by 
multiplying the margin per litre for each 
BMSCC category by the volume of milk 
supplied within each BMSCC category 
and summing the five calculations.
Industry Results
The gains in industry returns due to the 
10–30% movement from one cell count 
category to a lower one were calculated 
as the difference between the baseline 
industry returns and the improved indus-
try returns (Table 9). A 10% movement 
in milk supplies from higher to lower 
BMSCC categories saw an increase in 
industry returns relative to the baseline 
of €6.6 million per annum, increasing 
to €19.4 million per annum with a 20% 
improvement in milk supplied and €37.7 
million per annum with a 30% improve-
ment in milk supplies.
Discussion
This analysis highlights that the costs 
of mastitis are incurred across the dairy 
industry. While the largest component of 
the cost is at farm level, the processing 
industry is also incurring a share of the 
costs. The opportunity across the indus-
try of improving the national average 
BMSCC is significant and readily achiev-
able. A reduction in the national BMSCC 
of 10,000 cells/mL would result in an 
estimated industry gain of €6.6 million 
per annum, thus highlighting the value 
of a national mastitis programme. This is 
considering only moderate improvements; 
Table 8. Proportion of suppliers producing milk within each bulk milk somatic cell count category currently 
and the assumed improvement in suppliers examined in the scenario analysis
Proportion of producers in each BMSCC1 
category (,000 cells/mL)
Current
Scenarios
10% Movement2 20% Movement 30% Movement
<100 3.3 5.9 11.2 19.5
100–200 25.8 26.5 27.7 28.4
200–300 33.6 32.5 30.2 27.1
300–400 21.9 21.2 19.8 17.2
>400 15.4 13.9 11.1 7.8
National average somatic cel count (cells/mL) 281,432 271,760 262,088 252,415
1BMSCC=bulk milk somatic cell count.
210%, 20% and 30% movement refers to a movement of producers from one cell count category to the next 
lower BMSCC categories where possible, i.e. lowest cell count category there is no movement. 
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more significant improvements would sub-
stantially increase the value of the Irish 
dairy industry.
Expansion Post-2015
The removal of milk quota by 2015 (CAP 
Health Check 2008) presents a wealth of 
opportunities for the Irish dairy industry. 
In anticipation of this the Department 
of Agriculture, Food and the Marine in 
Ireland have set a number of dairy indus-
try targets to be achieved by 2020, the 
most significant of which is a 50% increase 
in the volume of milk produced by 2020 
(Food Harvest 2020, Department of 
Agriculture, Food and the Marine 2010). 
Considering the current national aver-
age BMSCC of 281,432 cells/mL and a 
national herd of 1,060,300 (CSO 2012); 
reducing this BMSCC by 100,000 cells/
mL results in an estimated increase in 
milk output of 142.1 million litres nation-
ally, equating to 5% of the Food Harvest 
2020 target. Expansion in Ireland is well 
underway with an additional 100,000 dairy 
replacement heifer calves born in 2012 
relative to 2008 (Shalloo, Ryan and French 
2012). Expanding herd size in the pres-
ence of high herd SCC will present many 
challenges (i.e. management, high on farm 
costs etc.) and may limit the number of 
cows that one individual can carry. As the 
Irish dairy industry is expanding farmers 
and processors need to be aware of the 
costs associated with mastitis and focus 
on it to motivate themselves to implement 
effective mechanisms to reduce the impact 
on farm and processor returns.
Effective mechanisms
As demonstrated in the analysis presented 
here, as BMSCC increased, milk price 
decreased and the values per kg of fat 
and protein decreased which was not lin-
ear. There was a significant advantage of 
reducing cell count even under the lower 
cell count categories. For example a reduc-
tion in cell count from the 200,000–300,000 
to the 100,000 to 200,000 cells/mL cat-
egory resulted in a milk price increase of 
0.37c/L. Payment systems, either in the 
form of a penalty or bonus or both, are 
effective tools to encourage reductions in 
the national BMSCC profile (Sampimon, 
Sol and Kock 2005, Valeeva, Lam and 
Hogeeven 2007). Currently many Irish 
milk processors continue to pay the base 
milk price up to a BMSCC of 400,000 
cells/mL, only imposing penalties after this 
BMSCC threshold. Such a system (i) does 
not incentivise farmers to reduce BMSCC 
below 400,000 cells/mL, implying that they 
only need to meet the EU regulations and 
(ii) does not optimise farm and processor 
returns. The analysis presented in the cur-
rent paper showed that there should be a 
difference of 0.96 cents per litre between 
milk supplied with a BMSCC of 100,000 
cells/mL and milk supplied with a BMSCC 
of >400,000 cells/mL. Incorporating this 
Table 9. Incremental gain in industry returns for each improvement in milk suppliers scenario examined
Analysis  National average 
BMSCC1 (cells/mL)
 Incremental gain relative to the 
baseline national returns, €m
Current  281,432  0.0
10% movement2 271,760  6.5
20% movement  262,100  19.4
30% movement  252,420  37.6
1BMSCC=bulk milk somatic cell count.
210%, 20% and 30% movement refers to a movement of producers from one cell count category to the next 
lower BMSCC categories where possible, i.e. lowest cell count category there is no movement.
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into a payment system would send a strong 
and serious signal to farmers that (i) keep-
ing the farm BMSCC below 400,000 cells/
mL is not sufficient and (ii) reinforcing 
this point by highlighting that a BMSCC 
<100,000 cells/mL is optimal. International 
research emphasises the importance of a 
blended penalty bonus system which seeks 
to reduce high SCC milk producers and 
maintain low SCC milk producers (Berry 
et al. 2006; Nightingale, Dhuyvetter and 
Schukken 2008).
CellCheck is the national mastitis con-
trol programme in Ireland which is coor-
dinated and facilitated by Animal Health 
Ireland. This programme provides the 
knowledge to reduce SCC on farm, how-
ever raising awareness of the costs of 
mastitis at farm level is the first step in 
reducing the national SCC (Lam et al. 
2007; Huijps et al. 2008). To assist this 
farmer awareness/education process many 
tools have been developed internationally: 
the Dutch cost of mastitis tool (Huijps 
et al. 2008) the New Zealand SmartSAMM 
Gap Calculator and the Australian 
Countdown Down Under Mastitis Model 
(Larcombe and Shephard 2004). Based on 
the success of these tools a similar decision 
support tool was developed for Ireland 
(CostCheck) using the analysis carried out 
by Geary et al. (2012). This tool is avail-
able on the Teagasc and Animal Health 
Ireland websites. 
Conclusions
The analysis presented here highlights 
that the current national average BMSCC 
of 281,000 cells/mL has a considerably 
negative impact on farm, processor and 
overall industry profitability. If correc-
tive measures are not taken at farm and 
processor level the unrealised poten-
tial of the national industry in terms of 
milk production, dairy product volume 
and dairy product quality will become 
more significant as the industry expands. 
Ongoing communication of these mes-
sages is essential to raise awareness at 
farm and processor level. Thereafter, the 
implementation of effective bonus/pen-
alty payment systems and the continuous 
provision of on-farm supports highlight-
ing best practices are key to reducing the 
national average BMSCC. 
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